Using the PEG framework with analyst consensus forward EPS growth of 23.3%, Hologic, Inc. has a fair value of $103.07 based on NTM EPS (FY2026) of $4.43. The current PEG ratio is 0.73.
PEG < 1 = bargain, 1–1.5 = fair, > 2 = expensive.
PEG is most informative for high-growth companies — the PEG sweet spot.
| EPS Growth RateForward | 23.3% |
| Adjusted Growth (clamped 8–25%) | 23.3% |
| Fair P/E | 23.3x |
| NTM EPS (FY2026) | $4.43 |
| Fair Value | $103.07 |
| Period | EPS Est. | Growth | Analysts |
|---|---|---|---|
| FY2025 (actual) | $2.49 | — | — |
| FY2026E | $4.43 | +77.9% | 12 |
| FY2027E | $4.83 | +9.0% | 12 |
| FY2028E | $5.17 | +7.2% | 8 |
| FY2029E | $5.75 | +11.1% | 7 |
4Y Forward EPS CAGR: 23.3%
| Year | Net Income | EPS | YoY |
|---|---|---|---|
| FY2021 | $1.9B | $7.21 | — |
| FY2022 | $1.3B | $5.13 | -28.8% |
| FY2023 | $456.0M | $1.83 | -64.3% |
| FY2024 | $789.5M | $3.32 | +81.4% |
| FY2025 | $565.7M | $2.49 | -25.0% |
4Y Historical EPS CAGR: -23.3%
The PEG Fair Value uses the Price/Earnings-to-Growth framework. A stock is fairly valued when its P/E ratio equals its earnings growth rate (PEG = 1.0). This model adds dividend yield to the growth rate per the original PEGY formula.
Growth rate priority: analyst consensus forward EPS CAGR (when ≥ 3 analysts cover the stock), falling back to historical EPS CAGR. Using EPS rather than net income avoids distortion from share buybacks. The growth rate is clamped between 8% and 25% — below 8% would undervalue stable earners, while above 25% would overvalue unsustainable spikes.